Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · IEX Real-Time Price · USD
63.53
+1.12 (1.79%)
At close: Apr 23, 2024, 4:00 PM
64.23
+0.70 (1.10%)
After-hours: Apr 23, 2024, 7:37 PM EDT
Exact Sciences Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Exact Sciences stock have an average target of 91.14, with a low estimate of 73 and a high estimate of 121. The average target predicts an increase of 43.46% from the current stock price of 63.53.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Exact Sciences stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 9 | 10 | 10 | 10 | 9 |
| Buy | 5 | 6 | 6 | 5 | 5 | 4 |
| Hold | 4 | 4 | 3 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 19 | 19 | 17 | 17 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $100 | Strong Buy | Maintains | $100 | +57.41% | Apr 3, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $100 → $90 | Strong Buy | Maintains | $100 → $90 | +41.67% | Feb 22, 2024 |
| Benchmark | Benchmark | Hold → Strong Buy Upgrades $91 | Hold → Strong Buy | Upgrades | $91 | +43.24% | Jan 2, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $90 | Strong Buy | Initiates | $90 | +41.67% | Dec 14, 2023 |
| Wolfe Research | Wolfe Research | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 13, 2023 |
Financial Forecast
Revenue This Year
2.89B
from 2.50B
Increased by 15.61%
Revenue Next Year
3.30B
from 2.89B
Increased by 14.05%
EPS This Year
-0.85
from -1.13
EPS Next Year
0.02
from -0.85
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.0B | 3.5B | 4.0B | 4.4B | 4.9B |
| Avg | 2.9B | 3.3B | 3.7B | 4.2B | 4.6B |
| Low | 2.8B | 3.1B | 3.5B | 4.0B | 4.4B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 20.7% | 22.0% | 21.0% | 17.3% | 16.3% |
| Avg | 15.6% | 14.0% | 12.7% | 12.8% | 10.7% |
| Low | 10.5% | 7.5% | 4.7% | 6.9% | 4.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.32 | 0.85 | 2.05 | 1.60 | 2.70 |
| Avg | -0.85 | 0.02 | 0.91 | 1.55 | 2.62 |
| Low | -1.26 | -0.82 | 0.26 | 1.49 | 2.52 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 11,347.0% | 76.2% | 74.1% |
| Avg | - | - | 4,948.3% | 71.2% | 69.1% |
| Low | - | - | 1,374.8% | 64.5% | 62.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.